Olema Pharmaceuticals, Inc. OLMA Q3 2025 earnings
Reported November 10, 2025 · Before market open
EPS estimate-$0.44
Next report
Aug 10, 2026 (In 4 weeks)EPS estimate-$0.53
Financials
Q3 2025Valuation & ratios
Versus estimates
Diluted EPS
Ask the moment Olema Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Olema Pharmaceuticals, Inc. report Q3 2025 earnings?
- Olema Pharmaceuticals, Inc. (OLMA) reported Q3 2025 earnings on November 10, 2025 before market open.
- What were Olema Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
- Olema Pharmaceuticals, Inc. reported diluted EPS of $-0.49 for Q3 2025.
- Did Olema Pharmaceuticals, Inc. beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.44 by $0.05.
- How did Olema Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 18.3% from $-0.60.
- Where can I find Olema Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-273228) and the 10-Q periodic report (0001193125-25-273236) directly on SEC EDGAR. The filing index links above go to sec.gov.